PACAREG: a Multicenter Registry Trial in Pancreatic Ductal Adencarcinoma

Recruiting now

Conditions studied: Pancreas Adenocarcinoma, Pancreas Cancer

In brief

PaCaReg is a multicenter registry trial aiming in the assessement of clinical, epidemiological and biological profiles in patients with pancreatic ductal adenocarcinoma

Key facts

Study ID

NCT04099134

Run by

University of Ulm

People needed

5000

Starts

2018-10-10

Expected to finish

2029-10-01

Last updated by the study team

2019-09-25

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Treatment naive histologically or cytologically proven pancreatic ductal adenocarcinoma (PDAC) or highly suspicious diagnosis (only pre-curative-intended resection)
• Age =>18 years
• written informed consent

You may not qualify if…

• papillary cancer
• neuroendocrine pancreatic tumors

Where it is running

• Universitätsklinikum Ulm — Ulm, Germany (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.